RCT | Effectiveness of genotype-specific tricyclic antidepressant dosing in patients with major depressive disorder

Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial – JAMA Network Open

Commentary on Twitter

Genotype-guided tricyclic antidepressant dosing may help patients with depression reach faster therapeutic plasma concentrations, with potentially fewer adverse effects. https://t.co/06cIaQjmwV pic.twitter.com/ZBdXZLeWc3

— JAMA Network Open (@JAMANetworkOpen) May 8, 2023